Evidence map›Paper›PMID 35207657›Full record

ArticleJournal of personalized medicine2022

Design and Development of an Intelligent Clinical Decision Support System Applied to the Evaluation of Breast Cancer Risk.

Manuel Casal-Guisande, Alberto Comesaña-Campos, Inês Dutra, Jorge Cerqueiro-Pequeño, José-Benito Bouza-Rodríguez

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
10.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Manuel Casal-GuisandeDepartment of Design in Engineering, University of Vigo, 36208 Vigo, Spain.ORCID 0000-0003-1494-8145
Alberto Comesaña-CamposDepartment of Design in Engineering, University of Vigo, 36208 Vigo, Spain.ORCID 0000-0002-3409-8996
Inês DutraDepartment of Computer Sciences, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.ORCID 0000-0002-3578-7769
Jorge Cerqueiro-PequeñoDepartment of Design in Engineering, University of Vigo, 36208 Vigo, Spain.ORCID 0000-0001-8617-595X
José-Benito Bouza-RodríguezDepartment of Design in Engineering, University of Vigo, 36208 Vigo, Spain.ORCID 0000-0002-1235-7264
Universidade do Porto · PT

Funding

Consellería de Educación, Universidade e Formación Profesional e Consellería de Economía, Emprego e Industria da Xunta de Galicia ED481A-2020/038
6 · The paper itself

Abstract

Breast cancer is currently one of the main causes of death and tumoral diseases in women. Even if early diagnosis processes have evolved in the last years thanks to the popularization of mammogram tests, nowadays, it is still a challenge to have available reliable diagnosis systems that are exempt of variability in their interpretation. To this end, in this work, the design and development of an intelligent clinical decision support system to be used in the preventive diagnosis of breast cancer is presented, aiming both to improve the accuracy in the evaluation and to reduce its uncertainty. Through the integration of expert systems (based on Mamdani-type fuzzy-logic inference engines) deployed in cascade, exploratory factorial analysis, data augmentation approaches, and classification algorithms such as k-neighbors and bagged trees, the system is able to learn and to interpret the patient's medical-healthcare data, generating an alert level associated to the danger she has of suffering from cancer. For the system's initial performance tests, a software implementation of it has been built that was used in the diagnosis of a series of patients contained into a 130-cases database provided by the School of Medicine and Public Health of the University of Wisconsin-Madison, which has been also used to create the knowledge base. The obtained results, characterized as areas under the ROC curves of 0.95-0.97 and high success rates, highlight the huge diagnosis and preventive potential of the developed system, and they allow forecasting, even when a detailed and contrasted validation is still pending, its relevance and applicability within the clinical field.

Indexed as

breast cancerclinical decision support systemdata augmentationdesign science researchexpert systemsexploratory factorial analysismachine learningmedical algorithm

Identifiers

PMID35207657
PMCPMC8880667
OpenAlexW4210619109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.